Kyotorphin
Also known as: L-Tyrosyl-L-Arginine · Tyr-Arg · KTP
An endogenous neuro-dipeptide with non-opioid analgesic properties and anti-amyloid activity, studied for pain management and Alzheimer's.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~18 minutes
Research dosing
Subcutaneous injection or intranasal
Mechanism of Action
Stimulates met-enkephalin release from neurons and inhibits amyloid-beta aggregation through direct peptide-peptide interaction.
Key Research Areas
Frequently Asked Questions
What is Kyotorphin?▾
How does Kyotorphin work?▾
What is the recommended dosage for Kyotorphin?▾
What is the half-life of Kyotorphin?▾
Is Kyotorphin FDA approved?▾
Research Disclaimer
The information provided about Kyotorphin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.